RE:Confused...The MedX management team since the start of 2020 secured the single largest PO from Brazil in the companies history, representing $1,000,000 in hardware sales and once deployed a recuring revenue stream of ~$2,000,000 annually, raised over $1,000,000 in the most brutal stock markets in recent history, mostly from institutions and recieved regulatory clearance in Brazil in record time as the management team said they would.
The management team recently stated they would expand into neighboring countries as they have found a financial model that is replicable and the need in countries near the equator is great.The share price at the beginning of the year was $.012 and now sits at$.09 I suspect as the market realizes this is not the end of the world MedX will start to reflect its true value. MedX will be cash flow positive this year just on executing the Brazilian order so not a lot of downside risk and lots of upside in my opinion. Time will tell. So far management has delivered.